Thromb Haemost 2007; 97(02): 169-170
DOI: 10.1160/TH07-01-0007
Editorial Focus
Schattauer GmbH

Retinal vein occlusion disease and platelet activation: Will antiplatelet therapy be a promising therapeutic strategy for patients with retinal vein occlusion disease in the future?

Suzanne Fateh-Moghadam
1   Medizinische Klinik mit Schwerpunkt Kardiologie, Campus Virchow-Klinikum, Charite-Universitätsmedizin, Berlin, Germany
,
Meinrad Gawaz
2   Medizinische Klinik III, Universitätsklinikum Tübingen, Tübingen, Germany
› Author Affiliations
Further Information

Publication History

Received 05 January 2007

Accepted 05 January 2007

Publication Date:
25 November 2017 (online)